Welcome to the Cell-based Artificial Blood Technology Development Consortium. Global challenges such as population aging, declining birth rates, and the COVID-19 pandemic have created a critical shortage of blood. To address this, the Korean government launched our consortium in April 2023 as a multi-ministerial initiative, aiming to create a reliable, sustainable blood supply beyond conventional donations. Our mission is clear: to develop safe, transfusable cultred red blood cells and platelets from stem cells, transform the blood supply paradigm, and ultimately secure a stable blood supply for both today and future generations. As a transfusion medicine specialist, I have long been passionate about providing safe and reliable blood to the public. While producing blood components from stem cells is a formidable challenge, I am confident that through collaboration and dedication, we will achieve our goal of commercial-scale cell-based blood production. I look forward to the continued support of government agencies, partner organizations, and researchers as we advance this transformative mission. The KCABP (Korean Cell-based Artificial Blood Project) is dedicated to the development of advanced cell-based artificial blood technology.